Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Acne Awareness Month: Skin health and medical cannabis
Acne is estimated to affect approximately 95% of people aged between 11 and 30 years old and is the eighth most common skin disease worldwide. In the UK specifically, it’s one of the most common skin conditions, with the country in the top 10 globally for diagnoses in adolescents and young people. Our skin contains part of the endocannabinoid system, the complex cell-signalling network responsible for keeping our skin healthy by regulating important bodily processes like inflammation and oil (sebum) production.
Quick reads
Articles
International Epilepsy Day 2026: medical cannabis access in the UK
International Epilepsy Day 2026 offers a timely look at epilepsy care in the UK. With over 630,000 people affected here in the UK, this guide explains how peoplle with epilepsy can legally acces medical cannabis treatment, along with seizure management research, and how legal frameworks continue to shape treatment options.
Sinking our teeth into medical cannabis and dentistry
To celebrate National toothache day, we thought it would be appropriate to sink our teeth into the topic of dentistry in the landscape of medical cannabis, and discuss how cannabis use can affect and impact oral health.
The benefits of staying sober past January
Although Dry January drew to a close last week, the benefits of staying sober can be felt year round, and enjoying alcohol in moderation is one of the best ways to naturally boost your overall health and general wellbeing.
Medical cannabis in the UK: A survey of Healthcare Professional’s perspectives
Grow Pharma, a UK-based medical cannabis company, recently released the findings of their latest survey, targeted at discovering how healthcare professionals feel about cannabis-based medicines, and what experiences they have had with them since their legalisation in 2018.








